activated protein C (PPL/Novo Nordisk)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameactivated protein C (PPL/Novo Nordisk)
Drug Alias Nameactivated protein C
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVitamin K-dependent protein C stimulantsCoagulation factor inhibitors
TargetsCoagulation factorVitamin K-dependent protein C
Therapy Area/IndicationsVenous ThrombosisMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPpl Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/SPpl Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisMyocardial InfarctionStroke

Other Information

ATC CodeN/A
Related LinksN/A